This model mimics the proliferative stage of ROP and DR10, and is widely used to study retinopathy pathogenesis and test potential anti-angiogenic therapies, including the early experimental work evaluating anti-VEGF therapies11. The gene discussed is VEGFA; the disease is retinopathy of prematurity.